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ABSTRACT 
Microalgae are more than ever of paramount importance: nutrition, cosmetic, energy, biotechnology tools … 
Wisely used CRISPR/Cas9 technology can help industries to overcome some issues and increase production yield 
of some valuable compounds. However, the following review shows that it is too early for both routine and 
industrial applications. Different transfections techniques were applied, nevertheless, inside the same laboratory 
different electroporation devices and conditions have been used. Moreover, genomic editing efficiency were often 
too low. In order to define which technique is the best suited for each microalgae it is urgent to lead some studies 
comparing the CRISPR mediated genome editing upon different transfection techniques and conditions. This 
review highlights that the scientific community needs to set for each microalgae the right protocol to follow and 
be able to compare the results from one laboratory to another. Finally, some techniques were not tested in order to 
introduce the CRISPR technology inside eukaryotic microalgae and increase the genome-editing yield. In that 
sense recombinant Cas9 or CPF1 coupled to cell penetrating peptides or gold nanoparticles as well as tunable 
expression vectors (optogenetic, chemically induced etc…) could be very interesting to develop.  
Keys words: Microalgae; cell; peptide; improvement; efficiency; genome; CPF1; Cas9; CRISPR 
АННОТАЦИЯ 
Микроводоросли имеют как никогда первостепенное значение: инструменты для питания, косметики, 
энергии, биотехнологии ... Мудро использованная технология CRISPR / Cas9 может помочь 
промышленности преодолеть некоторые проблемы и увеличить выход некоторых ценных соединений. 
Тем не менее, следующий обзор показывает, что это слишком рано для обычных и промышленных 
приложений. Различные методы трансфекции были применены, тем не менее, внутри одной и той же 
лаборатории были использованы различные устройства электропорации и условия. Более того, 
эффективность геномного редактирования часто была слишком низкой. Чтобы определить, какой метод 
лучше всего подходит для каждой микроводоросли, необходимо срочно провести некоторые 
исследования, сравнивающие CRISPR-опосредованное редактирование генома при различных методах 
трансфекции и условиях. В этом обзоре подчеркивается, что научное сообщество должно установить для 
каждого микроводоросля правильный протокол, которым нужно следовать, и иметь возможность 
сравнивать результаты из одной лаборатории в другую. Наконец, некоторые методы не были 
протестированы для того, чтобы внедрить технологию CRISPR внутри эукариотических микроводорослей 
и увеличить выход для редактирования генома. В этом смысле рекомбинантный Cas9 или CPF1, связанный 
с проникающими в клетку пептидами или наночастицами золота, а также с перестраиваемыми векторами 
экспрессии (оптогенетическими, химически индуцированными и т. Д.) Может быть очень интересным для 
разработки. 
Ключевые слова: микроводоросли; клетка; пептид; улучшение; эффективность; геном; CPF1; cas9; CRISPR 
 
1. Introduction: Microalgae are important biological resources that 
have a wide range of biotechnological and industrial 
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applications such as; biofuel, bio–sequestration of 
CO2, aquaculture, bioremediation, agriculture, 
cosmetics and recombinant proteins production [1, 2, 
3, 4, 5, 6, 7, 8]. Genomic engineering improvement 
is critical in order to increase further the microalgae 
production of high–value products and bio–energy 
[9], while creating organism less demanding and/or 
more resistant for industry purposes. 
Nowadays, although scientist community manage to 
transform microalgae chloroplast with some 
successes in order to express proteins of interest, 
nuclear transformation remains quite difficult, 
random and labor intensive. 
As discussed and reviewed by [10], transformation 
techniques were applied few microalgae compared 
to the huge diversity this denomination encompass 
[11], most of them conducted on C. reinhardtii as a 
model organism. Research teams often use plasmids 
to conduct their experiments [10], homologous 
recombination can be used in order to insert 
transgenes during chloroplast transformation but 
nuclear transformation remains more a random event 
[12]. Moreover, stability of the transgene and gene 
silencing [13, 14] could also occur rendering such 
transformation process difficult to achieve or almost 
impossible in few cases. It was pointed out that the 
homologous recombination frequency in microalgae 
is, we quote, “too low for adaptation as a 
recommended technology” [10]. Some exceptions 
like Nannochloropsis sp. strain W2J3B present an 
efficient homologous recombination process [15] 
but it was not applicable in other Nannochloropsis 
strains. Indeed, ideally both the industry and the 
scientists want a technique not only able to knockout 
genes but also to modify and tune the genome at will, 
in a precise manner. Traditional techniques do not 
provide enough precision to do it. Doing a point 
mutation at a precise location to modify an 
endogenous enzyme in a clean, controlled, manner is 
something we could not do easily until recently. 
Genomic positional effects, random insertion and 
genomic rearrangements are all limitations that 
compel researchers spending a lot of time screening 
for “the right transformant”. 
The use of plasmids are convenient but if such 
problems occur looking for an enzyme able to edit 
and regulate the genome in a “DNA free” fashion 
could be something valuable if it can enter the cell, 
being easily directed to the organelle and location of 
interest. 
As a consequence alternatives, were tested to edit the 
genome using endonucleases. Transcription 
Activator–Like Effector Nuclease (TALEN) have 
been in microalgae but results using those two labor 
intensive techniques seem to be difficult to achieve 
[15,16,17,18] or Zinc–Finger Nuclease (ZFN) [19] 
have been used in microalgae but results using those 
two labor intensive techniques seem to be difficult to 
achieve. 
Clustered regularly interspaced short palindromic 
repeats (CRISPR) system using the RNA–guided 
engineered nuclease (RGEN) Cas9 is able to target a 
specific genomic region thanks to single guide RNA 
abbreviated sgRNA [ 20, 21, 22], it that emerged as 
an easier, versatile and reliable technique to insert, 
remove and tune the genome. It is a powerful tool for 
everyone willing to edit the nuclear genome 
knocking–out or knocking–in genes by Homology 
Directed Repair (HDR) [20, 23], but also repressing 
or activating endogenous genes transcription by 
CRISPR interference [24, 25, 26, 27, 28, 29, 30]. 
CRISPR/Cas9 technology could circumvent the use 
of exogenous genes or other DNA sequences thus 
being more ethically acceptable [31, 32]. It was 
extensively studied in vegetables like Arabidopsis 
thaliana, tobacco, tomato, maize and rice [33, 34, 35, 
36, 37, 38, 39, 40, 41, 42]. Compared to 
CRISPR/Cas9, TALEN and ZFN are more 
expensive and time consuming as well [43. Finally, 
a DNA free CRISPR/Cas9 mediated genomic edition 
can lead to a “non–GMO” plant or microalgae [31]. 
Consequently, some studies have been done [44, 45, 
46, 47, 48], trying to apply the CRISPR/Cas9 
technology to microalgae genetic tailoring, some of 
them using a preassembled endonuclease. This 
review aims to provide solutions and future 
prospects in order to improve the CRISPR system 
efficiency in microalgae. First and foremost, we 
present what results have been obtained so far for 
each microalgae, related to technical context and 
pointing some issues that deserve to be clarified. 
After this overview, the discussion will provide 
guidelines and ideas for future project in order to 
improve the efficiency in microalgae. 
2. Eukaryotic microalgae  
2.1. Chlamydomonas reinhardtii 
Some studies have been done concerning the use of 
the CRISPR/Cas9 system in C. reinhardtii [44, 47, 
50]. Published in 2014, the first attempt used a codon 
optimized expression vector [45] in Chlamydomonas 
CC–503 strain, a mutant strain lacking an intact cell 
wall. The authors never used the same strain and 
nothing was written in a view to informing those 
decisions. CC–4349cm15mt– [44] and CC–124 [47] 
were used in further studies. They construct several 
vectors encoding for both the Cas9 gene and its 
corresponding sgRNA in conjunction with mutated 
exogenous reporter genes such as hygromycin, green 
fluorescent protein, or Gaussia luciferase. 
In order to assess the ability to mutate the 
endogenous genome, another strategy targeting the 
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endogenous FKBP12 gene was set to generate 
rapamycin resistant Chlamydomonas strain [51, 31] 
assessing the capability to mutate the C. reinhardtii 
genome. Information is gathered about the construct 
and techniques are herein presented in table 1. Like, 
hygromycin, GFP, Gaussian luciferase genes, the 
FKB12 targeted sequence is in close proximity or 
contain restriction enzyme sites. The goal was to 
digest none mutated DNA thus enriching the PCR 
pool with mutated sequences. This technique is 
based on several suppositions and only reveals 
mutants with a destroyed restriction site; then it only 
shows a proportion of all mutagenic events. 
Nevertheless, the authors questioned themselves 
about the efficacy of CRISPR/Cas9 in microalgae 
saying that after 16 independent [53]. 
They discover that the Cas9 by itself is toxic 
in Chlamydomonas using a catalytically dead Cas9 
(D10A/H840A) double mutant called dCas9. It is the 
same dCas9 used in CRISPR interference (CRISPRi) 
in order to modulate transcription as described in 
many articles [28, 30]. They used antibiotic 
resistance containing vector in order to enrich the 
microalgae population with cells harboring the 
dCas9 encoding construct. After such selection only 
6 clones, among 33 picked–up, displayed “intact 
dCas9” genes but no signal could have been detected 
by western–blot analysis. Of course increasing 
efficacy of CRISPR/Cas9 technology in microalgae 
will be as important as controlling its toxicity. Cas9 
mRNA was detectable but not the corresponding 
ribonucleoprotein. This also gives rise to concern 
about CRISPR interference (CRISPRi) in C. 
reinhardtii since this technique would require an 
intact dCas9 to modulate the genome. At this point, 
what causes Cas9 protein down regulation or 
degradation remains unraveled.  Although, we can 
notice that toxicity is probably not completely 
dependent on DNA processing since catalytically 
dead Cas9 seems to be toxic as well. 
A first part of the answer was investigated 
in 2016 [46, 49]. We will describe their methods and 
findings before pointing out details each one should 
have in mind in the future. Given the alleged Cas9 
toxicity in C. reinhardtii the research group opted for 
a “preassembled” ribonucleoprotein (RNP). It was 
already used before in several organism including 
plants [54, 55, 56, 57, 58, 59, 60, 61, 62]. Use of 
DNA–free RNP Cas9 is considerably faster 
compared to plasmid driven Cas9–sgRNA 
production, considering all the steps the tailoring and 
testing of a plasmid with optimized codon and 
ribosome binding sequence (RBS) can take. But 
more than that, following the cell entrance and 
subsequent DNA cut, preassembled Cas9 seems to 
be short lived, potentially reducing off–target and 
mosaicism (Kim et al., 2014; Ramakrishna et al., 
2014). 
Shin et al. [49] targeted three distinct genes: 
MAA7, CpSRP43 and ChlM by electroporating the 
ribonucleoprotein with or without resistance 
encoding vector into CC–124 C. reinhardtii cells. In 
order to test the efficacy of each sgRNA they tested 
it using Cas9 digestion of PCR amplified genomic 
regions encompassing the Cas9 cut site. The sgRNA 
unable to promote a proper DNA cleavage during the 
in–vitro assay was unable to generate any mutant, 
suggesting that a preliminary in–vitro test for each 
sgRNA is a wise move we should keep in mind for 
further studies before running time consuming 
mutagenic screen, the authors recommended it 
rightly, then it is not surprising giving past 
publications [55, 56]. As we can see later the other 
papers using CRISPR in microalgae never tested 
their sgRNA in comparable in–vitro test.  
MAA7 mutant is 5–fluoroindole resistant, 
the wild type version encoding the tryptophan 
synthase beta subunit (TSB) [62, 63, 64], while 
CpSRP43 and ChlM mutants can be selected by a 
bleached color phenotype. Both CpSRP43 and ChlM 
were co–transfected with a hygromycin resistance–
encoding vector in order to select the transfected 
population.  
The total targeting efficacy per cell of MAA7 
reached 8.9 × 10−8 and a total of 8 clones were 
isolated. Seven of them displayed 3bp long indels 
leading to point mutation instead of the frameshift 
they expected in order to generate a proper knockout, 
the eighth clone sequencing showing a 33 bp 
insertion. Conveniently, the mutation modified a 
conserved RPDAN [46, 52, 48, 31, 49] amino acid 
motif critical for the Alpha–Beta subunit interaction 
which is necessary for the enzymatic reaction [63, 
64].  
Previous work reported the use of NHEJ–
repair mediated knock–in for both CpSRP43 and 
ChlM gene modification. The three isolated mutants 
for the CpSRP43 gene were light green similarly to 
CC–4561 and CC–4562 deletion mutants used as 
positive control. Unfortunately, PCR and sequencing 
analysis revealed a major problem. 2650 bp, from the 
selection vector, were integrated at the Cas9 cut site 
together with a 13 bp sequence with unknown origin. 
It was a single copy insertion. The selection vector 
called Vec–2 do not contain any sequence matching 
the cutting site region thus, they concluded that the 
insertion was NHEJ–repair mediated [66].  An 
interesting fact not discussed in that paper appeared 
in figure 5. PCR analysis show that several 
“Regions” of the vector are indeed present in the 
mutants and not in the wild-type. The control of the 
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experiment is the vector alone, in absence of a proper 
dCas9 that should have been used. The figure 5, part 
b [49] shows clearly that both “Region B” (1662 bp) 
and the hygromycin resistance region (287 bp) of the 
vector were inserted in the Vec–2 condition, 
meaning without the Cas9. The clone CpSRP43 20–
1, electroporated with both Vec–2 and Cas9–sgRNA 
complex, also display a similar pattern and colony 
with a dark–green color probably coming from a cell 
where only the Vec–2 entered. The emerging 
question is, why “Region B” and hygromycin 
resistance region integrate by them self into the 
genome and not parts of “Region C” or “Region A”? 
Is the electroporation the suitable transformation 
approach in this case? Is there any other technics that 
could lead to a different result? To answer those 
questions we need to compare various 
transformation technique and strategies, which still 
has to be explored. 
The ChlM case confirmed that something is 
going out of control. The main purpose using the 
RNA–guided engineered nucleases (RGEN) 
CRISPR/Cas9 being to do a precise and controlled 
modification of the genome, unwanted genomic 
integrations of exogenous DNA is thus inconvenient. 
Indeed, among 10 mutants displaying a lighter color 
phenotype, most of them contain at least one copy of 
the vector inserted, some containing two copies of it. 
Moreover, they described several rearrangement of 
the vector sequence together with some indels 
inserted next to the CRISPR/Cas9 cutting site as seen 
previously. Again, no homology was found between 
the vector and the ChlM gene sequence targeted by 
the Cas9 enzyme, leading to the conclusion that 
NHEJ–repair mediate those insertions. Interestingly, 
“Figure7 part a” [49], showing the result of the PCR 
analysis for several region of the vector do not show 
a control using the vector alone but only a regular 
wild–type. “Part b” of the same figure present the 
maps of the rearrangements for each mutants, which 
are apparently random, the author could not explain 
those genomic events. As a consequence it is 
difficult to draw predictions for further studies. Shin 
et al. [49] methods improved the CRISPR/Cas9 
efficacy in Chlamydomonas compared to previous 
results obtained by [47]. The MAA7–2, CpSRP43 
and ChlM experiments have a total targeting 
efficiency (per cell) of 8.9 × 10−8, 3.3 × 10−8 and 5.0 
× 10−8 respectively. The math being done using the 
number of cells used for electroporation as a total. 
Off–targets research do not find any mutations for 
MAA7 and CpSRP43 experiments, nevertheless 
both ChlM–4 and ChlM–21 clones are knock–in 
with insertions at another location. 
Baek et al. [46] used the DNA–free Cas9 
RNA–guided engineered nuclease to modify the 
CpFTSY and ZEP genes electroporating the RNA 
guided Cas9 complex into CC–4349cm15mt– strain 
cells. Reading the title we can think about a 
simultaneous double gene knockout but it is a two–
step double gene knockout. This third 
Chlamydomonas paper [46] do not bring new 
technical insights compared to the Shin SE et al. 
paper [49] but it confirmed the results obtained using 
DNA–free RGENs. They generate at first a ZEP 
knockout called ΔZEP and then modified the 
CpFTSY gene obtaining a ΔZEP/ΔCpFTSY 
transformant.  
ZEP gene encodes for Zeaxanthin 
epoxidase implicated in antheraxanthin and 
violaxanthin synthesis, CpFTSY is a receptor for 
chloroplast signal recognition particle (CpSRP) 
genes [67]. ZEP knock–out will enable Zeaxanthin 
accumulation and the additional CpFTSY knock–out 
is aimed to reduce chlorophyll antenna size allowing 
a higher intensity for the saturation of photosynthesis 
and a greater maximum photosynthetic rates (Pmax) 
[67, 68, 69] improving mass culture productivity 
under hight light. Indeed, the ΔZEP/ΔCpFTSY 
mutant displayed a greater growth and a Pmax 54 % 
higher at maximum light intensity compared to the 
ΔZEP mutant. Three sgRNAs directed against the 
CpFTSY gene were tested producing 0.007 %, 0.12 
% and 0.272 % indel frequency.
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Table 1: Summary of processing techniques used in CRISPR system in Eukaryotic microalgae studies. 
Transformation 
technique 
Electroporation Biolistic 
Transformation 
protocol and 
condition 
Bio–Rad Gene Pulser II. Cells 
were resuspended TAP 60mM 
sucrose to a density of 4x108 
cells/ml. 250 μL of cells was 
mixed with 2 g plasmids in an 
electroporation cuvette (4 mm 
gap) chilled for 5 min in a 16 
°C water bath prior to 
electroporation. One pulse at 
0.75 kV and 25 μF without 
resistance was applied. 
Biorad CM 830 Square Wave 
Electroporation System using 
cuvettes (2 mm gap). Cas9 (10 to 
40μg) and sgRNAs (7.5 to 30 μg) 
were incubated together at 37 °C 
for 30 min, and 300 μL (quantity 
must be in number cells not as a 
volume) were placed in the 
cuvette and cooled on ice for 5 
min. Electroporation was done at 
250 V and 15 ms interval. 
Bio–Rad Gene Pulser Xcell™ 
Electroporation Systems. 2 μg of 
linearized plasmid. 200 μg of 
Cas9 protein and 140 μg of 
sgRNA in a 4 mm gap 
electroporation cuvette during 5 
min at room temperature. 5x105 
cells were electroporated at 600 
V and 50 μF. Cf. GeneArt® 
Chlamydomonas Engineering 
Kits. 
Cells was mixed with 2 μg vector 
in a 2 mm gap electroporation 
cuvette. BTX ECM 630 
electroporation device was used 
with 11 kV/cm field strength, 
50μF capacitance, and 600 Ohm 
shunt resistance. 
Bio–Rad Biolistic PDS 1000/He 
Particle Delivery System. 
Tungsten M17 microcarriers 
(Bio–Rad) were coated with 2.5 
μg of vector. 0.5x108 cells was 
plated and grown for 1 day. 
Microalgae and 
strain 
Chlamydomonas reinhardtii, 
strain CC–503 (lacking intact 
cell wall) 
Chlamydomonas reinhardtii, 
strain CC–124 
Chlamydomonas reinhardtii, 
strain CC–4349 cw15 mt– 
Nannochloropsis oceanica, strain 
IMET1 
Phaedactylum tricornutum cells, 
strain CCMP2561 
Cas9 version 
Cas9 encoding vector DNA–free RNA–guided 
engineered nuclease (RGENs) 
DNA–free RNA–guided 
engineered nuclease (RGENs) 
Cas9 encoding vector Cas9 encoding vector 
Constructs 
Cas9 driven by Cauliflower 
mosaic virus (CaMV) 35S 
promoter and terminated by 
nopaline synthetase gene 
termination region (Tnos). 
sgRNA gene was flanked by 
Arabidopsis thaliana U6 
promoter and terminator. 
 None; the synthetised 
ribonucleoprotein is 
electroporated directly with or 
without an antibiotic resistance 
encoding vector. 
 None; the synthetised 
ribonucleoprotein is 
electroporated directly with or 
without an antibiotic resistance 
encoding vector. 
Vector harboring a hygromycin 
resistance (HygR). A codon 
optimized Cas9 controled by 
violaxanthin/chlorophyll (a) 
binding protein promoter (Pvcp) 
and α–tublin termination (Tatub) 
region. The sgRNA was driven by 
a V–type ATPase promoter 
(Patpase) and terminated with 
ferredoxin terminator (Tfd). 
Cas9 controled by the P. 
tricornutum LHCF2 promoter 
and LHCF1 terminator sequence. 
sgRNA expression was 
controled via P. tricornutum U6 
snRNA promoter and poly–T 
termination signal from Chr8 
(CM000611.1).  
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Endogenous 
gene targeted 
FKB12 gene 
(XM001693563.1; phytozome 
Cre13.g586300.t1.2) 
MAA7 gene (XM_001703345 
and XP_001703397); CpSRP43 
gene (XM_001703652 and 
XP_001703704)); ChlM gene 
(XM_001702328 and 
XP_001702380). 
CpFTSY and ZEP genes (the 
author do not mension the exact 
NCBI map they use) 
Nitrate Reductase NR (NR; 
g7988) 
CpSRP54 gene (Draft ID: 
Phatr2_35185, Chr7: 
NC_011675.1) 
sgRNA 
FKBP12 sgRNA 5–
GGCGTGGCCCAGATGTC
CAA–3 
MAA7–2 sgRNA 5–
CAUAGCGACCAUUUGCGUC
C–3; CpSRP43 sgRNA 5–
CGAUUCCGGCCUGCACCGG
C–3; ChlM sgRNA 5–
CCCGCCCGGCUGUGGCCCG
G–3 
CpFTSY sgRNA 5–
CGATCTTCAGAGCAGTGCG
G–3; ZEP sgRNA 5–
TCCGGCGAACGCACCTGGA
T–3 
NR sgRNA 5–
CAGAGCAAGGGCTTCAGCT
G–3 
CpSRP54 sgRNA 5–
CCGCCCTTCGTGAAGTACG
T–3 
Number of cell 
used 
1,6*109 (16 transformations 
were done and pulled 
together) 
0.9x108 5x105 n/a 0.5x108 
Efficiency 
claimed 
1,6x10–9 from 3.3x10(–8) to 8.9x10(–8) 0.56 % for ΔCpFTSY; 0.45 % for 
ΔZEP and 1,1% for 
ΔZEP/ΔCpFTSY 
1.22 % for flask no 5. 0.122 % for 
all ten flasks. 
31 % (or 16x10–8) 
Comments 
Dead–Cas9 experiment have 
shown that Cas9 is toxic per se. 
Small Indels inducing point 
mutations of the MAA7 encoding 
protein. Several plasmid DNA 
insertions at the Cas9 cut site, 
The same did both articles using 
DNA–free RGENs, yet they use 
different protocols and even 
different Chlamydomonas strain 
without justifying why. 
They worked on one flask out of 
ten (flask no 5). Then the results 
do not represent the total efficacy 
but the results for the flask no5 
only. 
8 out of 23 transformant obtained 
after culture in selection media. 
Single nucleotide insertion, 
small deletion and vector derived 
DNA integration. If we use the 
initial number of cells, we have 
an efficiency of 8 cells out of 
0.5x108, thus 16x10–8. 
References 
[52] [49] [46] [50] [48] 
 
 
Евразийский Союз Ученых (ЕСУ) # 2 (59), 2019 37  
  
 
7 
 
НАУКИ О ЗЕМЛЕ  
The best one produced 0.56 % mutation frequency in 
a second round of experiment. Five ZEP sgRNA 
were evaluated by targeted deep sequencing as well, 
indel frequency spreading from 0.094 % up to 0.456 
%. Of course, the best sgRNAs results were 
encouraging, yet the efficacy varies a lot from one 
sgRNA to another. Best results were encouraging 
and thus emphasized. Highlighting the best results 
obtained is of course something that should be done 
but looking at the whole data we see results varying 
from one sgRNA to another but also for the same 
sgRNA: in the CpFTSY example the efficacy of the 
sgRNA double at the second use without any 
explanation. The zeaxanthin example is a great one 
because it shows what CRISPR mediated mutation 
could be very important in order to generate cell lines 
with improved high–value compound production. 
While the wild type Zeaxanthin quantity was 0.0062 
± 0.0005 fmol per cell, both ΔZEP and 
ΔZEP/ΔCpFTSY show amazing increase, up to 
0.1376 ± 0.0007 (22 fold increase) and 0.0827 ± 
0.0009 (13 fold increase) respectively. 
2.2. Phaedactylum tricornutum 
As reported in the introduction [18] and 
[17] managed to edit Phaedactylum tricornutum 
CCMP2561 strain genome using transcription 
activator–like–effector nucleases (TALEN). 
Nymark et al. [48] used Biolistic mediated co–
transformation of a home maid pKSdiaCas9_sgRNA 
vector and pAF6 Zeocin resistance vector. Biolistic 
is DNA–coated gold or tungsten micro–particles 
delivered at high–velocity such technique was used 
in various microalgae including P. tricornutum [70, 
71, 72]. They decided to target a gene implicated in 
the chloroplast signal recognition particle pathway 
named CpSRP54. As CpSRP43, those genes are 
convenient to target because they allow researchers 
to discriminate mutated cells easily using color 
alteration phenotype.  
The efficacy in this paper appear amazingly 
high compared to C. reinhardtii, giving 31% 
mutation frequency (8 out of 26 transformants) for 
CpSRP54 Researchers claimed as well the 
successful transformation and mutation of two 
additional genes with mutation frequency ranging 
from 25 to 63 %, without showing the data. This 
seems to be a huge improvement compared to 
Chlamydomonas papers previously presented and 
discussed.  
Jiang et al. [52] showed that Cas9 protein is 
toxic and impossible to detect in their study, in 
Phaedactylum tricornutum, [48] qRT–PCR was used 
to detect Cas9 levels but never show or talk about 
protein levels. They assume that Cas9 is not toxic in 
Phaedactylum tricornutum because relatively high 
levels of both Cas9 mRNA and sgRNA were found. 
Jiang et al. [52] also had good mRNA levels but they 
showed that Cas9 protein was absent, perhaps being 
rapidly degraded inside the cell. Here we cannot rule 
out that the Cas9 protein production is indeed 
repressed or the protein degraded so fast that the only 
time window available is the adaptation just after the 
transfection event. Scientist should find a same way 
to evaluate and compare their protocols. Talking 
about technique efficacy, [47] looked at the number 
of cell they initially used (1.6x109 cells) and the 
number of mutant they obtained, one.  
Among eight transformants successfully 
modified, one presents a 212–bp insertion 
corresponding to the used vector. As the author 
reported, such kind of phenomenon occurred in 
TALEN study [18] using biolistic transformation; 
although it seems that the integration rate was lower 
with biolistic compared to the various insertion seen 
in Chlamydomonas using electroporation. The OFF–
target effect were not investigated in P. tricornutum, 
it could have been great to have some results we can 
put in perspective with Chlamydomonas. 
2.3. Nannochloropsis oceanica 
 Genus Nannochlorospsis is part of both 
Heterokonta superphylum and 
Eustigamatophysceae class. The N. oceanica strain 
used was IMET1. Nannochloropsis is used in the 
industry and can produce a broad range of products, 
from biofuels to high–value compounds [73]. 
Techniques like nitrogen deprivation can double the 
quantity of lipids inside Nannochloropsis [74, 75,]. 
The Xu research team decided to mutate the nitrate 
reductase [50], an enzyme converting nitrate to 
nitrite, based on the knowledge they previously 
acquired working on the Nannochloropsis genome 
and metabolism (As a consequence, the mutant will 
grow under ammonium supplementation but should 
not grow in medium containing nitrate only. The 
efficacy spread between 1 % and 0.1 %. As in P. 
tricornutum, they used a vector driven codon 
optimized Cas9–sgRNA production [76, 77] 
containing a Hygromycin gene using endogenous 
promoters and terminators. The sgRNA targets a 
PvuII enzymatic restriction site containing sequence 
within the nitrate reductase gene, as reported for 
Chlamydomonas [47], so they can use it in order to 
enrich the DNA pull with mutated DNA since the 
mutation is designed to destroy the enzymatic site.  
 The Cas9 is HA tagged but they failed to 
detect it by western blot analysis while both Cas9 
mRNA and sgRNA were detected at good levels 
using qRT–PCR. Once again as shown for C. 
reinhardtii and P. tricornutum Cas9 protein level 
was not detected by western–blot analysis but Cas9 
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mRNA was easily measured. They also checked the 
functionality of the vector using fluorescence 
generated by the ble–mCherry protein, showing that 
the vector was indeed working.  
 The originality lays in the screening 
methods. 48 h post transformation, cells were plated 
in 10 hygromycin containing plates. 100 colonies 
were collected from each plate and pulled inside one 
flask. The subsequent culture (10 flask for 1000 
colonies) lasted 14 days before DNA extraction and 
analysis. Wang, Q. et al. [50] and colleagues 
employed restriction–enzyme digested nested PCR 
called nPCR/RE fallowed by next generation 
sequencing. A part of extracted DNA underwent 
enzymatic pretreatment and the other not. Treatment 
of PCR product with PvuII restriction enzyme 
generate two bands (223 bps and 172 bps) 
corresponding to non–edited DNA and a 395–bp 
band corresponding to mutated DNA. Enzymatic 
pretreatment enrich your PCR amplicons in 395–bp 
bands. Among 10 flasks, the number 5 was the only 
one showing a clear 395–bp long band after gel 
electrophoresis. 97 % were wild type DNA without 
pretreatment whereas the perfect match frequency 
was up to 54 % using the pretreatment enrichment 
technique. Mutations occurred at the Cas9 cut site, a 
majority of them displaying a 5–bp deletion pattern 
at a frequency of 1.22 %, as expected those numbers 
increased up to 42.19 % using pretreatment.  
We have to put those results in perspective because 
those efficiency percentages may concern flask 
number 5 only and not the whole group of 10 flasks. 
They estimated that the 5–bp deletion pattern 
account for 1 % since each flask were inoculated 
with 100 colonies. Said otherwise one colony may 
have been successfully transformed out of 100. 
Nevertheless, we have to be more careful here as 
they inoculated 10 flask with 100 colonies and flask 
number five only represent one tenth of the total 
amount of colonies picked up. Finally, the real 
efficiency percentage is perhaps 10 fold lower. The 
isolation and phenotyping were done from flask 
number five as well since it was the only one to 
provide satisfactory results. On the other side, the 
method (nPCR/RE) used to evaluate the technique 
rely on restriction site. As seen previously in 
Chlamydomonas, taking advantage of a restriction 
site to enrich a PCR pool in mutated DNA is nice, 
yet you may not be that lucky all the time. As a 
consequence, we have to think further about suitable 
techniques to check mutations and mutations 
efficiency independently of restriction site presence. 
3. Discussion 
  In this paper, we review the strategies and 
statuses of the use of CRISPR technology to improve 
the efficiency of Eukaryotic microalgae to produce 
these biologically active compounds. Several studies 
aimed to explore Cas9 genome editing technique in 
microalgae. Nevertheless, we can conclude that there 
is some room for technical improvement if the 
scientific community aims to use the CRISPR/Cas9 
system for further study. Cas9 protein toxicity issue 
needs to be addressed. Efficiency should be 
enhanced and comparable techniques and protocols 
are required in order to put results in perspective 
more easily. Mastering those parameters in some 
microalgae used as reference organism could lead to 
a more predictable and efficient use of the Cas9. To 
sum up; two main transfection techniques were used, 
electroporation and biolistic, and the Cas9–sgRNA 
complex can be present into the cell as a DNA–free 
ribonucleoprotein or expression vector.  
Transformation technique used to deliver 
the Cas9 needs to be improved. Microalgae can be 
transformed using several techniques: protoplasts 
[79, 80, 81, 82, 83, 84, 85] glass beads [71], biolistic 
[71, 72, 73], electroporation [85] and agrobacterium 
[86, 87, 88], and scientists can target several organels 
like nucleus [89, 90, 91], mitochondria [92], and 
chloroplast [93, 90, 94, 95, 96, 97, 98]. 
Agrobacterium delivered CRISPR/Cas9 gave nice 
results in maize for example [36] but was not 
implemented for Cas9 delivery in eukaryotic 
microalgae. Trying other methods in order to 
transform microalgae is definitely something the 
scientific community has to do in order to choose the 
best one for each eukaryotic  
Additionally, the insertion of DNA 
sequence from selection vector used in that 
transformation is a problem we need to unravel. In 
fact, all the publications only showed the capability 
to obtain a knock–out using the CRISPR technology 
but with pour efficiency; knock–out generation 
being only one CRISPR technique among others. 
In order to control the mutation process, we 
need to insert a sequence of interest where we want, 
how we want. Point mutation like, Shin et al. [49] 
have shown were obtained unwittingly. Fortunately 
for them, the point mutation occurred at a strategical 
place, disrupting the activity of the enzyme. In order 
to have a better control of the knockout process we 
can insert a “stop–tag” inducing a frameshift, long 
enough to be seen by PCR, allowing a low cost 
genotyping and screening step before going forward 
with sequencing. “stop–tag insertion” could include 
or not specific sequence sequences in order to 
genetically “brand” the modified microalgae by the 
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industrial or the research institute: a genetic “foot–
print” or “bar code” aimed to make the algae 
recognizable as part of a given project and property 
of a specific developer and/or owners. “Stop–tag” 
could also be used in conjunction with other “foot–
prints” elsewhere in the genome in order to create 
another level of security by conjunction and data 
cross–checking. We propose and consider two 
alternative options over and above: a cell penetrating 
CRISPR/Cas9 and an inducible vector with tunable 
expression mode.  
Cell penetrating CRISPR/Cas9 (CPP–
RGEN or CPP–Cas9) was studied in human cells by 
Suresh Ramakrishna and colleagues [56] but it was 
also studied in TALEN and ZFN systems [100, 101]. 
The percentage of indel frequency was similar in the 
CPP–RGEN treated cell compared to plasmid 
delivery condition. We propose to use a cell 
penetrating peptide (CPP)–Cas9/sgRNA based 
strategy in order to transform some microalgae but 
also some cyanobacteria. Indeed translocation of 
FITC coupled CPPs were evaluated in C. reinhardtii 
[102] the results were encouraging, they also 
compared viability of cells using CPP with 
electroporated cells, showing that the later exhibited 
80 % decrease in viability whereas CPP decrease in 
viability do not exceed 18 % only. Viability is also 
an important parameter since Cas9 toxicity is a 
recurring subject. Plasmid pVEC was the most 
efficient CPP tested in Chlamydomonas (TAT, PEN 
and TRA were also tested). The same system using 
cell-penetrating peptide can be applied in 
cyanobacteria as shown by Han–Jung Lee team [103, 
104]. CPPs are not toxic for cyanobacteria, thus 
CPP–Cas9/sgRNA may provide in the future a fast 
and efficient way to modify both cyanobacteria and 
eukaryotic microalgae. CRISPR/Cas9 were also 
used in cyanobacteria. Expression vector driven 
Cas9 protein production was shown to be toxic as 
well in cyanobacteria in two independent studies 
[105, 106]. However, other papers showed that Cas9 
could be used to do CRISPRi (CRISPR interference) 
using dead Cas9 [107, 108, 109].  
 Has we discussed herein, a precise tailoring 
is necessary if we want to reach the next level of 
genomic modification in eukaryotic microalgae. 
Then we can wonder if co–transfection of DNA, 
sgRNA and Cas9 protein using CPP can be done in 
microalgae, the purpose could be the insertion of a 
“stop–tag” DNA construct (ultramer like) with 
homologous wings allowing a precise insertion in 
the genome and a cost effective screening using 
PCR. Using the same method, we can tag protein and 
modify enzyme in a very clean manner. In order to 
support the feasibility of such project we draw your 
attention to the article published by [110], studying 
CPP–dsRNA in several eukaryotic microalgae such 
as C. reinhardtii, C. vulgaris, P. tricornutum, and D. 
salina.  
Another path could be the design of a 
tunable vector with an antibiotic resistance cassette 
providing a first microalgae population harboring the 
vector in a “silent” mode. The Cas9 vector from the 
purified population can be “activated” by a drug, 
triggering the Cas9 mRNA and protein synthesis. 
The Rheoswitch system from the Intrexon Company 
can provide a dose dependent mechanism 
(https://www.dna.com/Technologies/RheoSwitch) 
so we would be able to set the precise dose to 
minimize toxicity and maximize indels frequency. 
To our knowledge such technique was used in 
human cell [111, 112, 113] and we propose here to 
use it in order to control Cas9 production and 
toxicity. Nevertheless, other system can be 
considered since several systems exist to trigger 
CRISPR editing and interference using, temperature, 
chemicals or light [114, 115]. 
4. Conclusion 
Use of CRISPR technology need to be improved, 
robust protocol have to be found and time-tested. A 
particular attention should be paid to reproducibility: 
the scientific community have to use identical, or 
comparable, devices and protocols in order to draw 
valuable comparisons. Finally, it may be interesting 
to be more curious, or adventurous, testing the 
technique with other types of microalgae, so many 
are neglected. 
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